Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label follow-up study of levetiracetam in primary generalized seizures
2004-001997-13Phase 3Completed
- Sponsor
- UCB
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of levetiracetam in epilepsy and idiopathic epilepsy (IGE), sponsored by UCB. Primary endpoint: Subjects with at least six months of seizure freedom. Started Oct 2004; status: completed.
02
Drugs
levetiracetam
03
Conditions
epilepsyidiopathic epilepsy (IGE)
Beyond the preview
Go deeper on 2004-001997-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001997-13.